Riverbridge Partners LLC Abbott Laboratories Transaction History

Riverbridge Partners LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$90.19 - $110.4 $5,681 - $6,955	63 Added 0.4%	15,788 $1.74 Million
Q4 2023 Jan 24, 2024	BUY	$90.19 - $110.4 $5,681 - $6,955	63 Added 0.4%	15,788 $1.74 Million
Q3 2023 Feb 15, 2024	SELL	$95.53 - $114.62 $6,018 - $7,221	-63 Reduced 0.4%	15,725 $1.52 Million
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $503 - $561	-5 Reduced 0.03%	15,725 $1.71 Million
Q2 2021 Jul 26, 2021	SELL	$105.79 - $124.53 $2,433 - $2,864	-23 Reduced 0.15%	15,730 $1.82 Million
Q1 2021 Apr 21, 2021	BUY	$108.84 - $128.23 $2,503 - $2,949	23 Added 0.15%	15,753 $1.89 Million
Q4 2020 Jan 22, 2021	SELL	$105.0 - $114.42 $1,470 - $1,601	-14 Reduced 0.09%	15,730 $1.72 Million
Q3 2020 Oct 08, 2020	SELL	$91.64 - $111.29 $7,881 - $9,570	-86 Reduced 0.54%	15,744 $1.71 Million
Q2 2020 Jul 08, 2020	BUY	$76.57 - $98.0 $102,603 - $131,320	1,340 Added 9.25%	15,830 $1.45 Million
Q4 2019 Jan 14, 2020	SELL	$78.51 - $87.4 $36,821 - $40,990	-469 Reduced 3.14%	14,490 $1.26 Million
Q2 2019 Jul 10, 2019	BUY	$72.88 - $85.0 $1.09 Million - $1.27 Million	14,959 New	14,959 $1.26 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Riverbridge Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Riverbridge Partners LLC with notifications on news.